Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis

[1] Cotte E(2010)Selection of patients and staging of peritoneal surface malignancies World J Gastrointest Oncol 2 31-35

[2] Passot G(2005)The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 31 540-543

[3] Gilly FN(2009)Imaging of peritoneal carcinomatosis Cancer J 15 184-189

[4] Glehen O(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann Intern Med 151 W65-W94

[5] Pomel C(2011)QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Annals of internal medicine 155 529-536

[6] Appleyard TL(2013)Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) Abdom Imaging 38 1422-1430

[7] Gouy S(2009)Multi-detector CT in peritoneal carcinomatosis: diagnostic role of thin slices and multiplanar reconstructions Abdom Imaging 34 49-54

[8] Rouzier R(2002)Peritoneal metastases: detection with spiral CT in patients with ovarian cancer Radiology 223 495-499

[9] Elias D(2014)Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125 Revista espanola de medicina nuclear e imagen molecular 33 22-27

[10] Gonzalez-Moreno S(2013)Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT Clin Nucl Med 38 93-97

[1] Cotte E(2010)Selection of patients and staging of peritoneal surface malignancies World J Gastrointest Oncol 2 31-35

[2] Passot G(2005)The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 31 540-543

[3] Gilly FN(2009)Imaging of peritoneal carcinomatosis Cancer J 15 184-189

[4] Glehen O(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann Intern Med 151 W65-W94

[5] Pomel C(2011)QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Annals of internal medicine 155 529-536

[6] Appleyard TL(2013)Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) Abdom Imaging 38 1422-1430

[7] Gouy S(2009)Multi-detector CT in peritoneal carcinomatosis: diagnostic role of thin slices and multiplanar reconstructions Abdom Imaging 34 49-54

[8] Rouzier R(2002)Peritoneal metastases: detection with spiral CT in patients with ovarian cancer Radiology 223 495-499

[9] Elias D(2014)Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125 Revista espanola de medicina nuclear e imagen molecular 33 22-27

[10] Gonzalez-Moreno S(2013)Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT Clin Nucl Med 38 93-97